Cancer Research Technology

Advancing Discoveries to Beat Cancer

  • Contact Us
  • Careers


  • Home
  • About CRT
  • Discovery & Development
  • Licensing Portfolio
  • Scientists & Inventors
  • Institutes & Charities
  • Research Tools
  • News & Events
  • Home
  • tools
  • antibodies
  • p01.html
  • P100
  • Antibodies
  • Cell Lines
  • Mouse Models

Refine search

Applications

  • All Applications
  • Acetone (71)
  • ChIP (2)
  • ELISA (192)
  • FACS (132)
  • FITC (5)
  • Frozen (206)
  • Immunofluorescence (130)
  • Immunohistochemistry (52)
  • Immunoprecipitation (249)
  • Neutralising (40)
  • Paraffin embedded (132)
  • Western (422)

Research Area

  • All Research Area
  • Cancer Metabolism (49)
  • Cell Adhesion Proteins (49)
  • Cell Cycle Proteins (69)
  • Cytochrome P450 (12)
  • Cytokines, Growth Factors & Hormones (32)
  • DNA Repair & Replication (55)
  • Extracellular Matrix Proteins (4)
  • Fusion Protein, Epitope Tags, Markers & Reporter Proteins (16)
  • Leukocyte Markers (91)
  • Non-Cancer (45)
  • Receptors (10)
  • Secondary Detection (5)
  • Signal Transduction (33)
  • Stem Cells (10)
  • Structural Proteins (47)
  • Tissue Specific Antigens (54)
  • Transcriptional Regulators (36)
  • Tumour Suppressor Proteins (21)
  • Viral Proteins (39)
  • Zebrafish (7)

Can't find the research tool you're looking for?

For more information please contact +44 (0) 20 3469 6300 click to email

Research Tools - Antibodies

Keyword search (separate search terms with commas)

Page 6 of 32 pages « First  <  4 5 6 7 8 >  Last »

Cyclin-dependent kinase 2 (cdk2) AN21.2

Cyclin-dependent kinase 2 (cdk2) AN4.3

CDw75 (CD75s) ZB55

CDX1 CDX1/123a

Carcinoembryonic Antigen (CEA) NCRC16

Carcinoembryonic antigen-related cell adhesion molecules 5 & 6 (CEACAM5, CD66e; CEACAM6, CD66c) CD66 C and E subtypes (NCA) By114

Chromodomain-helicase-DNA-binding protein 4 (CHD4/Mi-2b) CHD4 3F2/4

Cig2 CIG2 3A11/5

Cisplatin modified native DNA CP9/19

Cisplatin Modified Native DNA CP9/19

Clathrin heavy chain STo 3H9

C-type lectin-like receptor (CLEC-2) 17D9

Complement receptor 1 (CR1, CD35) E11

Complement Receptor Type 1 (CR1, CD35) To5

Complement component (3d/Epstein Barr virus) receptor 2 (CR2, CD21) 21A/5

Complement component (3d/Epstein Barr virus) receptor 2 (CR2, CD21) BU32

Complement component (3d/Epstein Barr virus) receptor 2 (CR2, CD21) BU33

Complement component (3d/Epstein Barr virus) receptor 2; long form (CR2, CD21L) R4/23

cROS 4-6G

cROS 5-4E


Back to top


Explore CRT

About CRT

  • Who we are
  • What we do
  • Our track record
  • Our history & Milestone

Discovery & Development

  • Drug Discovery
  • CRT's Discovery Laboratories
  • Imaging & Diagnostics
  • Drug Development

License Portfolio

  • Small Molecules
  • Biological Therapeutics
  • Medical Devices
  • Biomarkers
  • Enabling Technology

Scientists & Inventors

  • Have an Idea?
  • Benefits of working with CRT
  • Commercialising your invention
  • Funding your discovery

Institutes & Charities

  • Our services
  • Benefits of working with CRT

Research Tools

  • Antibodies
  • Cell Lines
  • Mouse Models

News & Events

  • Press Releases
  • Events

Cancer Research Technology

  • Contact Us
  • Careers
  • Terms & Conditions

© Cancer Research Technology 2012